Trial intelligence / Profile preview

Hyaluronic acid pharmacokinetics study of ECM-E in adults ≥40 years

jRCT1091220177Completed

Sponsor
Adaptgen Pharmaceutical
Start
Apr 2014
Countries
1
01

Overview

Open-label trial of hyaluronic acid (2 arms), sponsored by Adaptgen Pharmaceutical. Primary endpoint: Blood hyaluronic acid pharmacokinetics. Started Apr 2014; status: completed.

02

Drugs

hyaluronic acid

Beyond the preview

Go deeper on jRCT1091220177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call